nausea

Summary :-Mirati Therapeutics, Inc. (NASDAQ: MRTX), a targeted oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted…

Highlights: Terlivaz is the first and only FDA-approved treatment for adults with HRS involving rapid reduction in kidney function. Terlivaz is expected…

Summary : IMCIVREE now available for chronic weight management in adult and pediatric patients 6 years of age and older with monogenic…